Paul V. Maier - Jun 17, 2025 Form 4 Insider Report for International Stem Cell CORP (ISCO.OB)

Role
Director
Signature
/s/ Russell Kern, Attorney-in-Fact
Stock symbol
ISCO.OB
Transactions as of
Jun 17, 2025
Transactions value $
$0
Form type
4
Date filed
6/20/2025, 08:18 AM
Previous filing
Jan 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MAIER PAUL V Director C/O INTERNATIONAL STEM CELL CORP., 9745 BUSINESSPARK AVENUE, SAN DIEGO /s/ Russell Kern, Attorney-in-Fact 2025-06-19 0001182615

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISCO.OB Stock Option (Right to Buy) Award $0 +30K $0.00 30K Jun 17, 2025 Common Stock 30K $0.13 Direct F1
transaction ISCO.OB Stock Option (Right to Buy) Award $0 +533K $0.00 533K Jun 17, 2025 Common Stock 533K $0.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying such option shall vest on the earlier of (a) June 17, 2026, or (b) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant.
F2 The shares underlying such option shall vest in equal quarterly increments through June 17, 2026, with the first increment vesting on September 17, 2025.